Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease
Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of Acute Coronary Syndrome Patients With Multi-Vessel Disease
Sponsor: Assiut University
Listed as NCT03138473, this observational or N/A phase trial focuses on ACS - Acute Coronary Syndrome and Multi Vessel Coronary Artery Disease and remains completed. Sponsored by Assiut University, it has been updated 12 times since 2018, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Mar 2022 — Jul 2024 [monthly]
Completed
-
Sep 2021 — Mar 2022 [monthly]
Completed
Status: Recruiting → Completed
▶ Show 7 earlier versions
-
Feb 2021 — Sep 2021 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — Feb 2021 [monthly]
Unknown Status
-
Jul 2020 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Aug 2018 — Jul 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Aug 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Jun 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assiut University
For direct contact, visit the study record on ClinicalTrials.gov .